Dizal Pharma's Corporate Minority Round

Dizal Pharma raised a round of funding on November 27, 2017.

Dizal Pharma, a joint venture between AstraZeneca and the Chinese Future Industry Investment Fund (managed by SDIC), aims to develop and commercialize new drugs in China.…

Articles about Dizal Pharma's Corporate Minority Round: